Clinical Trials Browser

Phase 1 × Childhood Solid Tumors × Granulocyte Colony-Stimulating Factor × Clear all

NCT02392793 2021-02-09

Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies

Phase 1 Completed

Other solid neoplasm

Childhood Solid Tumors